Response to "Post-marketing strategies for medicine''

被引：0

|

作者：

Goldhammer, A. ^{[1
]}

机构：

[1] Pharmaceut Res & Manufacturers Amer, Washington, DC USA

来源：

CLINICAL PHARMACOLOGY & THERAPEUTICS | 2008年 / 83卷 / 01期

关键词：

D O I：

10.1038/sj.clpt.6100444

中图分类号：

R9 [药学];

学科分类号：

1007 ;

摘要：

引用

收藏

页码：25 / 25

页数：1

相关论文

共 50 条

[11] POST-MARKETING EVALUATION OF DRUGS
REMINGTON, RD
DRUG THERAPY, 1977, 7 (09) : 59 - 61
[12] POST-MARKETING MONITORING OF DRUGS
LEWIS, JA
CHILVERS, C
JOURNAL OF THE ROYAL SOCIETY OF MEDICINE, 1985, 78 (10) : 874 - 877
[13] Post-marketing surveillance of sertindole
Toumi, M
INTERNATIONAL JOURNAL OF PSYCHIATRY IN CLINICAL PRACTICE, 2002, 6 : S33 - S35
[14] POST-MARKETING DRUG SURVEILLANCE
WALDEN, RJ
PRICHARD, BNC
BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, 1978, 6 (03) : 191 - 192
[15] POST-MARKETING SURVEILLANCE OF DRUGS
HARCUS, AW
WARD, AE
SMITH, DW
BRITISH MEDICAL JOURNAL, 1979, 2 (6194): : 867 - 867
[16] A PRESCRIPTION FOR POST-MARKETING SURVEILLANCE
ROUTMAN, KD
DRUG & COSMETIC INDUSTRY, 1980, 126 (06): : 60 - 64
[17] POST-MARKETING SURVEILLACE OF THE RETINOIDS
Diane ChenHead Drug Safety F HoffmannLa Roche CoPostfach CH Basel
中国临床药理学杂志, 1988, (04) : 222 - 227
[18] POST-MARKETING SAFETY STUDIES Three design aspects for high quality post-marketing cohort studies
Fralick, Michael
Kesselheim, Aaron S.
BMJ-BRITISH MEDICAL JOURNAL, 2017, 357
[19] POST-MARKETING SURVEILLANCE OF NEW MEDICINES
SMITHELLS, RW
BRITISH MEDICAL JOURNAL, 1977, 2 (6096): : 1218 - 1218
[20] FDA post-marketing safety decisions
Klein, Donald F.
JOURNAL OF CLINICAL PSYCHIATRY, 2006, 67 (08) : 1305 - 1306

← 1 2 3 4 5 →